2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid (BioDeep_00000180553)

   

human metabolite blood metabolite


代谢物信息卡片


2-{2-[2-(4-phenoxy-2-propylphenoxy)ethyl]-1H-indol-5-yl}acetic acid

化学式: C27H27NO4 (429.19399820000007)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCCC1=C(C=CC(=C1)OC2=CC=CC=C2)OCCC3=CC4=C(N3)C=CC(=C4)CC(=O)O
InChI: InChI=1S/C27H27NO4/c1-2-6-20-18-24(32-23-7-4-3-5-8-23)10-12-26(20)31-14-13-22-17-21-15-19(16-27(29)30)9-11-25(21)28-22/h3-5,7-12,15,17-18,28H,2,6,13-14,16H2,1H3,(H,29,30)

描述信息

同义名列表

6 个代谢物同义名

2-{2-[2-(4-phenoxy-2-propylphenoxy)ethyl]-1H-indol-5-yl}acetic acid; {2-[2-(4-phenoxy-2-propylphenoxy)ethyl]-1H-indol-5-yl}acetic acid; 2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid; 2-(2-(4-Phenoxy-2-propylphenoxy)ethyl)indole-5-acetate; 2-PPPE-iaa; PPEIA CPD



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Joseph M Rutkowski, Zhao V Wang, Ae Seo Deok Park, Jianning Zhang, Dihua Zhang, Ming Chang Hu, Orson W Moe, Katalin Susztak, Philipp E Scherer. Adiponectin promotes functional recovery after podocyte ablation. Journal of the American Society of Nephrology : JASN. 2013 Feb; 24(2):268-82. doi: 10.1681/asn.2012040414. [PMID: 23334396]
  • Mathieu Laplante, William T Festuccia, Geneviève Soucy, Pierre-Gilles Blanchard, Alexandra Renaud, Joel P Berger, Gunilla Olivecrona, Yves Deshaies. Tissue-specific postprandial clearance is the major determinant of PPARgamma-induced triglyceride lowering in the rat. American journal of physiology. Regulatory, integrative and comparative physiology. 2009 Jan; 296(1):R57-66. doi: 10.1152/ajpregu.90552.2008. [PMID: 18971352]
  • Sandra Sena, Isaac R Rasmussen, Adam R Wende, Alfred P McQueen, Heather A Theobald, Nicole Wilde, Renata Oliveira Pereira, Sheldon E Litwin, Joel P Berger, E Dale Abel. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology. 2007 Dec; 148(12):6047-53. doi: 10.1210/en.2006-1559. [PMID: 17823261]
  • Mathieu Laplante, William T Festuccia, Geneviève Soucy, Yves Gélinas, Josée Lalonde, Joel P Berger, Yves Deshaies. Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism. Diabetes. 2006 Oct; 55(10):2771-8. doi: 10.2337/db06-0551. [PMID: 17003342]
  • Andrew G Howarth, William B Wiehler, Malarvannan Pannirselvam, Yanfen Jiang, Joel P Berger, David Severson, Todd J Anderson, Chris R Triggle. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice. The Journal of pharmacology and experimental therapeutics. 2006 Jan; 316(1):364-70. doi: 10.1124/jpet.105.086397. [PMID: 16249369]
  • Henrike Sell, Joel P Berger, Pierre Samson, Gino Castriota, Josée Lalonde, Yves Deshaies, Denis Richard. Peroxisome proliferator-activated receptor gamma agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob/ob mice. Endocrinology. 2004 Aug; 145(8):3925-34. doi: 10.1210/en.2004-0321. [PMID: 15131020]
  • Mathieu Laplante, Henrike Sell, Karen L MacNaul, Denis Richard, Joel P Berger, Yves Deshaies. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes. 2003 Feb; 52(2):291-9. doi: 10.2337/diabetes.52.2.291. [PMID: 12540599]